Strategic Diagnostics Inc.

Strategic Diagnostics Inc., headquartered in Newark, DE USA, develops, manufactures and markets biotechnology-based products and services across industrial, academic, diagnostic and pharmaceutical markets — from food safety test kits to diagnostic-grade antibody solutions.

For over 20 years, SDI has created antibodies and reagents which advance our customers’ and partners’ immuno-based work, helping them reduce time, labor, and costs while increasing accuracy and reliability of results. Unique SDI capabilities include Genomic Antibody Technology™ (GAT) for rapid development of diagnostic-grade clinical assays and research projects — from antibody candidate to critical high-quality reagent formulation. With GAT, the antibody is more likely to recognize the native conformation of target proteins, resulting in highly-reactive antibodies that enable research scientists to save time, money, and increase success rates.

SDI also develops, manufactures and markets immune-assay-based test kits for field testing and laboratory use. These products are used for food pathogen safety, water quality testing, and contaminated waste site assessment and remediation.

SDI continues to leverage its expertise in immunology, proteomics, biological detection and other bio-reactive technologies to broaden its position in the diagnostics, life science and pharmaceutical research and development markets.